Molecular Designs Simplifies High-Risk HPV Clinical Research with New Multiplex PCR Panel

BIRMINGHAM, Ala., Nov. 18, 2025 /PRNewswire/ -- Molecular Designs, a developer and manufacturer of molecular infectious-disease assays, today announced the launch of its Human Papillomavirus (HPV) ...
Philstar.com

Early detection, timely intervention keys to cervical cancer elimination

The initiative highlighted how the screening model, using advanced, high-capacity testing and strong referral linkages, can ...
Hosted on MSN

DNA test reveals dozens of secret siblings

After a 23 and Me DNA test, the woman discovered she has multiple half-siblings she never knew about. Trump admin weighs major change to Social Security disability benefits Las Vegas police roll out ...
EurekAlert!

New one-hour, low-cost HPV test could transform cervical cancer screening in Africa and beyond

Materials used to run the HPV LAMP assay. A cytology brush is used to collect a cervicovaginal swab sample into ThinPrep buffer. Samples are lysed in screw-on tubes and lysate is added to LAMP ...
News Medical

Simple, affordable HPV test delivers results in less than an hour

A team of researchers led by Rice University, in collaboration with colleagues in Mozambique and The University of Texas MD Anderson Cancer Center, has developed a simple, affordable human ...
Medscape

Blood-Based HPV Test Detects Oropharyngeal Cancer Early

A novel multifeature human papillomavirus (HPV) whole genome sequencing liquid biopsy assay detected circulating tumor HPV DNA (ctHPV DNA) with 79% sensitivity and 100% specificity up to 7.8 years ...
eLife

Monitoring circulating cell-free HPV DNA in metastatic or recurrent cervical cancer: clinical significance and treatment implications

In this prospective pilot observational study, levels of HPV cfDNA in serum samples from 28 patients with recurrent or metastatic HPV-positive cervical cancer were measured via digital droplet ...
Newsweek

New Blood Test Gives Cancer Warning 10 Years Early

A new blood test can identify cancers of the head and neck caused by the human papillomavirus (HPV) up to 10 years before symptoms appear. This is the discovery of Mass General Brigham researchers who ...
EurekAlert!

Blood test identifies HPV-associated head and neck cancers up to 10 years before symptoms

Human papilloma virus (HPV) causes around 70% of head and neck cancers in the United States, making it the most common cancer caused by the virus, with rates increasing each year. Unlike cervical ...
Healio

HPV testing uptake in oropharyngeal cancer still ‘problematic’ despite recommendations

Please provide your email address to receive an email when new articles are posted on . HPV testing rates in oropharyngeal cancer have increased over time but remain suboptimal. Testing uptake varies ...
eLife

Serum, Cell-Free, HPV-Human DNA Junction Detection and HPV Typing for Predicting and Monitoring Cervical Cancer Recurrence

This is a valuable study that suggests that HPV-human DNA junctions can be identified from cfDNA in women with cervical cancer and that detection of these junctions is indicative of recurrence. The ...